Sign up
Quantellect · Congress · Issuer Profile
NYSE: PFEPfizer Inc
HealthcareMkt Cap $173.95BCongress ownership rank #14

Pfizer Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 482 trades in Pfizer Inc (NYSE: PFE) since 2013, across 84 members, worth an estimated $6.7M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 229 buys against 250 sells, a modestly sell-led skew, with Democratic members responsible for 63% of the trades and Republican members 37%. The most recent disclosure shown was filed November 2026, and Rohit Khanna has filed the most PFE transactions among those shown, with 12. Other recent filers include Tommy Tuberville, Alan Armstrong, and Gilbert Cisneros. One notable disclosed move was a purchase by Rohit Khanna on July 7, 2026, up 16.6% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Pfizer Inc's current Quantellect Tide Score is 52 out of 100 (High Tide), Top 46% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Pfizer Inc (PFE) stock overview and the complete trade table below.

Data updated

Trades
18
Politicians
5
Filings
13
Disclosed Vol
$500.51K
Buys
7
39%
Sells
11
61%

Price & congressional trade timeline

Party breakdown

Pfizer congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Nov 5, 2026Oct 7, 202629 daysBuy
$15,001 - $50,000
+0.21%Spouse
Oct 7, 2026Sep 25, 202612 daysBuy
$1,001 - $15,000
-2.13%Spouse
Oct 7, 2026Sep 11, 202626 daysBuy
$1,001 - $15,000
+1.23%Child
Oct 7, 2026Sep 4, 202633 daysSell
$15,001 - $50,000
-1.37%Spouse
Aug 7, 2026Jul 7, 202631 daysBuy
$1,001 - $15,000
+16.58%Child
Jul 6, 2026Jun 16, 202620 daysSell
$1,001 - $15,000
+7.76%Spouse
Jul 16, 2026Jun 8, 202638 daysSell
$15,001 - $50,000
+9.52%Joint
Jul 6, 2026Jun 2, 202634 daysSell
$15,001 - $50,000
+9.82%Child
Jun 9, 2026May 15, 202625 daysBuy
$1,001 - $15,000
+10.78%Spouse
May 11, 2026Apr 13, 202628 daysBuy
$1,001 - $15,000
+4.33%Spouse
Go to

Pfizer (PFE) congressional trading FAQ

Can members of Congress legally trade Pfizer (PFE) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Pfizer (PFE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Pfizer (PFE) trades public?

Yes. Every congressional trade in Pfizer (PFE) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Pfizer (PFE)?

Members of Congress have disclosed 482 trades in Pfizer (PFE) worth $6.7M across 84 members, according to public STOCK Act filings.

Which members of Congress have traded Pfizer (PFE)?

Recent and active filers of Pfizer (PFE) disclosures include Rohit Khanna, Gilbert Cisneros, Tommy Tuberville. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Pfizer (PFE) more?

Across disclosed Pfizer (PFE) trades, 63% were by Democrats and 37% by Republicans, led by Democrats (63%).

What is the most recent congressional Pfizer (PFE) trade?

The most recent disclosed Pfizer (PFE) filing reported a buy by Rohit Khanna, filed Nov 4, 2026.

What is Pfizer (PFE)'s Tide Score?

Pfizer (PFE) has a Quantellect Tide Score of 52 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewPfizer (PFE) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.